Phase 4 COPD Clinical Trials
18 recruitingPhase 4
What is a Phase 4 trial?
Phase 4 trials, also called post-marketing studies, are conducted after a treatment has been approved and is available to the public. They monitor long-term effectiveness and safety in a broader population.
Showing 1–18 of 18 trials
Recruiting
Phase 4
Post-marketing Phase 4 Safety & Tolerability Study of Breztri aerosphereTM in Indian Patients With Chronic Obstructive Pulmonary Disease
Moderate to Severe COPD
AstraZeneca150 enrolled1 locationNCT06531798
Recruiting
Phase 4
Comparing Hydrocortisone and Prednisolone for Acute Exacerbation of Chronic Obstructive Pulmonary Disease (AECOPD)
Chronic Obstructive Pulmonary Disease (COPD)
Copenhagen Respiratory Research2,000 enrolled14 locationsNCT06892210
Recruiting
Phase 4
Actualities in Procedural Sedation: Remimazolam
ASA Class III/IV PatientsCOPD III/IVAge 65 and Older+1 more
Iuliu Hatieganu University of Medicine and Pharmacy200 enrolled1 locationNCT07362173
Recruiting
Phase 4
Genetic Variation in IgG in Alpha 1 Antitrypsin Deficiency
COPDAlpha 1-AntitrypsinAntibody Deficiency
University of Alabama at Birmingham30 enrolled1 locationNCT07135427
Recruiting
Phase 4
Compare the Effects of Nebulizer Versus Inhaler Based Therapy for COPD Using Long-acting Bronchodilators
COPD, Chronic Obstructive Pulmonary Disease
University of Tennessee Graduate School of Medicine72 enrolled1 locationNCT07133880
Recruiting
Phase 4
Clinical Study on the Treatment of Stable Bronchiectasis With Bailing Capsules Combined With Guben Kechuan Granules
COPDBronchiectasis
Second Affiliated Hospital, School of Medicine, Zhejiang University214 enrolled5 locationsNCT07114120
Recruiting
Phase 4
The Effects of Positive Airway Pressure on the Mucolytic Effects of NAC (TEAM)
AsthmaCOPD
University of California, San Francisco40 enrolled1 locationNCT06152653
Recruiting
Phase 4
Standard vs Targeted Oxygen Therapy Prehospital for Chronic Obstructive Pulmonary Disease
COPD ExacerbationCOPD Exacerbation Acute
Central Denmark Region1,888 enrolled1 locationNCT05703919
Recruiting
Phase 4
Bronchodilators and Lung Mechanics During Exercise in COPD
COPD
Dr. J. Alberto Neder25 enrolled1 locationNCT06825013
Recruiting
Phase 4
Effect of the Inhaled Triple Therapies Over the Small Airway in Biomass Exposure
COPD BronchitisPollution Related Respiratory Disorder
National Institute of Respiratory Diseases, Mexico128 enrolled1 locationNCT06571942
Not Yet Recruiting
Phase 4
Inhaled Bronchodilators to support the use of Beta-Blockers in Chronic Obstructive Pulmonary Disease (COPD).
COPDCardiac Disease
Waikato District Health Board36 enrolled1 locationACTRN12621001503819
Completed
Phase 4
The Vietnam COPD Asthma and Prevention of Smoking (VCAPS) 4 Trial
AsthmaCOPDSmoking
Woolcock Institute of Medical Research3,393 enrolled1 locationACTRN12620000649910
Terminated
Phase 4
Exploring the impact of chronic obstructive pulmonary disease (COPD) patient characteristics on inhaler device capability and inhaler device characteristics on treatment efficacy.
COPD
Campbelltown Hospital40 enrolled2 locationsACTRN12618000075280
Completed
Phase 4
Investigating the effectiveness of nebulised Pulmozyme (dornase alfa) in reducing inflammation in chronic airway disease
AsthmaChronic Obstructive Pulmonary Disease (COPD)
University of Newcastle30 enrolled1 locationACTRN12617000395336
Not Yet Recruiting
Phase 4
Simvastatin treatment for patients with Chronic obstructive pulmonary disease (COPD) and elevated C-reactive protein (CRP).
Chronic Obstructive Pulmonary Disease (COPD)Elevated CRP
Associate Professor Robert Young48 enrolled1 locationACTRN12615000491561
Not Yet Recruiting
Phase 4
Paroxetine for Anxiety in Patients with Chronic Obstructive Pulmonary Disease(emphysema).
AnxietyCOPD
Department of Respiratory Medicine, TQEH100 enrolled5 locationsACTRN12613000458730
Completed
Phase 4
Managing Inflammation in Chronic Obstructive Pulmonary Disease (COPD) [Mi COPD]
Chronic Obstructive Pulmonary Disease (COPD)
John Hunter Hospital134 enrolled1 locationACTRN12613000046707
Completed
Phase 4
Inhaled corticosteroids in Chronic Obstructive Pulmonary Disease (COPD)
Smoking-related COPD
GlaxoSmithKline35 enrolledACTRN12607000249459